Envista Holdings Corporation
NVSTNYSEHealthcareMedical Instruments & Supplies

About Envista Holdings

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone714-817-7000
Address
Building E, 200 South Kraemer Boulevard Brea, California 92821-6208 United States

Corporate Identifiers

CIK0001757073
CUSIP29415F104
ISINUS29415F1049
EIN83-2206728
SIC3843

Leadership Team & Key Executives

Paul A. Keel
Chief Executive Officer and Director
Eric D. Hammes
Senior Vice President and Chief Financial Officer
Mark E. Nance J.D.
Senior Vice President, General Counsel and Secretary
Mischa M. Reis
Senior Vice President of Strategy and Corporate Development
Robert Befidi Jr.
President of Diagnostics
Faez Kaabi
Vice President, Chief Accounting Officer and Corporate Controller
Andrew Chen
Chief Information Officer
Jim Gustafson
Vice President of Investor Relations
Paul Sumilas
Chief Compliance Officer
Suraj Satpathy
Chief Human Resources officer